Microbot Medical Inc (MBOT) - Total Liabilities
Based on the latest financial reports, Microbot Medical Inc (MBOT) has total liabilities worth $3.96 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Microbot Medical Inc - Total Liabilities Trend (1991–2025)
This chart illustrates how Microbot Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Microbot Medical Inc to evaluate short-term liquidity relative to the company's equity base.
Microbot Medical Inc Competitors by Total Liabilities
The table below lists competitors of Microbot Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bokusgruppen AB
ST:BOKUS
|
Sweden | Skr822.30 Million |
|
Bioxyne Ltd
AU:BXN
|
Australia | AU$14.45 Million |
|
Carbios
PA:ALCRB
|
France | €65.53 Million |
|
Taiwan Line Tek Electronic Co Ltd
TW:2462
|
Taiwan | NT$2.19 Billion |
|
Maywood Acquisition Corp. Class A Ordinary Shares
NASDAQ:MAYA
|
USA | $4.61 Million |
|
Glintt
LS:GLINT
|
Portugal | €111.19 Million |
|
Golconda Gold Ltd.
V:GG
|
Canada | CA$15.40 Million |
|
I Controls Inc
KO:039570
|
Korea | ₩178.69 Billion |
Liability Composition Analysis (1991–2025)
This chart breaks down Microbot Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Microbot Medical Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 22.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Microbot Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Microbot Medical Inc (1991–2025)
The table below shows the annual total liabilities of Microbot Medical Inc from 1991 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.99 Million | +59.54% |
| 2024-12-31 | $2.50 Million | -34.63% |
| 2023-12-31 | $3.83 Million | +70.20% |
| 2022-12-31 | $2.25 Million | -5.78% |
| 2021-12-31 | $2.39 Million | +21.06% |
| 2020-12-31 | $1.97 Million | -64.72% |
| 2019-12-31 | $5.59 Million | +17.35% |
| 2018-12-31 | $4.76 Million | +350.76% |
| 2017-12-31 | $1.06 Million | -36.84% |
| 2016-12-31 | $1.67 Million | -92.24% |
| 2015-12-31 | $21.55 Million | -18.84% |
| 2014-12-31 | $26.56 Million | -0.18% |
| 2013-12-31 | $26.60 Million | +64.36% |
| 2012-12-31 | $16.19 Million | +11.78% |
| 2011-12-31 | $14.48 Million | -4.24% |
| 2010-12-31 | $15.12 Million | -26.94% |
| 2009-12-31 | $20.70 Million | +6.56% |
| 2008-12-31 | $19.42 Million | +48.59% |
| 2007-12-31 | $13.07 Million | +4.73% |
| 2006-12-31 | $12.48 Million | +0.14% |
| 2005-12-31 | $12.46 Million | +16.72% |
| 2004-12-31 | $10.68 Million | +21.02% |
| 2003-12-31 | $8.82 Million | +16.99% |
| 2002-12-31 | $7.54 Million | -0.71% |
| 2001-12-31 | $7.60 Million | +11.48% |
| 2000-12-31 | $6.81 Million | -44.50% |
| 1999-12-31 | $12.27 Million | -18.17% |
| 1998-12-31 | $15.00 Million | -2.60% |
| 1997-12-31 | $15.40 Million | -35.02% |
| 1996-12-31 | $23.70 Million | +107.89% |
| 1995-12-31 | $11.40 Million | +18.75% |
| 1994-12-31 | $9.60 Million | +47.69% |
| 1993-12-31 | $6.50 Million | +8.33% |
| 1992-12-31 | $6.00 Million | +150.00% |
| 1991-12-31 | $2.40 Million | -- |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more